No Detail Found!

Early forecasting of COVID-19 case progression with hematological and biochemical parameters of patients in Egypt

Author(s)
Mohamed M A El-Sokkary Microbiology and Immunology department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
Ahmed M El-Baz Microbiology and Biotechnology department, Faculty of Pharmacy, Delta University for Science and Technology,Gamasa,Egypt
Rasha M El-Morsi Microbiology and Biotechnology department, Faculty of Pharmacy, Delta University for Science and Technology,Gamasa,Egypt
Kristina Keuper Department of Molecular Genetics, Faculty of Biology, Technical University of Kaiserslautern,Kaiserslautern,Germany
Salah El-Hawary Mansoura University,Mansoura,Egypt
Ahmed Shata Pharmacology department, Faculty of Medicine, Mansoura University, Mansoura, Egypt ;Clinical Pharmacy department, Faculty of pharmacy, Delta University for Science and Technology, Gamasa, Egypt
Galal Yahya Microbiology and Immunology Department, Faculty of Pharmacy, Zagazig University,Al Sharqia,Egypt
Abstract
The coronavirus pandemic 2019 (COVID-19) is changing the world and reshape all aspects of life. Side by side to global efforts to develop potential vaccines and effective drugs against COVID-19, clinical parameters scanning the prognosis of COVID-19 infection are badly required to help the clinicians in premature management of COVID-19 cases before critical progression. The main objective of our study is to specify reliable biomarkers which differentially change upon case progression and clearly reflect the extent of lung lesions. Forty-one patients from Mansoura area, confirmed for COVID-19 infection were classified according to the diameter of lung lesions measured by lung computed tomography (CT) into mild and severe cases including 66% and 34% of all patients, respectively. COVID-19 patients were followed since hospital admission for comparative studies covering measured biochemical and hematological parameters. Based on the degree of severity, five different biomarkers mainly; D-dimer, lactate dehydrogenase (LDH), C-reactive protein (CRP), lymphocytes and ferritin were found to clearly oscillate in response to COVID-19 infection and upon case transition from mild to severe. In our study, significantly higher levels of almost all the biomarkers except lymphocyte count, were detected in patients having severe complications of COVID-19 infection in contrast with nonsevere patients.
Publication Details
Page(s) 401-408
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 35, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
COVID-19, Lymphocytes, Ferritin, D-dimer, Covid-19, CRP, LDH
References
Bilgir O,Bilgir F,Calan M,Calan OG,Yuksel A .2015 .Comparison of pre- and post-levothyroxine high-sensitivity c-reactive protein and fetuin-a levels in subclinical hypothyroidism. Clinics (Sao Paulo), 70(2) : 97-101.
Bonaventura A,Vecchie A,Dagna L A .2021 .Endothelial dysfunction and immuno-thrombosis as key pathogenic mechanisms in COVID-19. , 21(5) : 319-329.
Chalmers S,Khawaja A,Wieruszewski PM,Gajic O,Odeyemi Y .2019 .Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: The role of inflammatory biomarkers. World J. Crit Care Med, 8(5) : 59-71.
Chan JF,Yuan S,Kok KH,To KK,Chu H,Yang J,Xing F,Liu J,Yip CC,Poon RW,Tsoi HW,Lo SK,Chan KH,Poon VK,Chan WM,Ip JD,Cai JP,Cheng VC,Chen H,Hui CK,Yuen KY .2019 .A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet., 395(10223) : 514-523.
Chen N,Zhou M,Dong X,Qu J,Gong F,Han Y,Qiu Y,Wang J,Liu Y,Wei Y,Xia J,Yu T,Zhang X,Zhang L X .2020 .Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet, 395(10223) : 507-513.
Chung M,Bernheim A,Mei X,Zhang N,Huang M,Zeng X,Cui J,Xu W,Yang Y,Fayad ZA,Jacobi A,Li K,Li S,Shan H S .2020 .CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV). Radiology, 295(1) : 202-7.
Fan BE,Chong VCL,Chan SSW,Lim GH,Lim KGE,Tan GB,Mucheli SS,Kuperan P,Ong KH .2020 .Hematologic parameters in patients with COVID-19 infection. , 95(6) : E131-E4.
Ferrari D,Motta A,Strollo M,Banfi G,Locatelli M .2020 .Routine blood tests as apotential diagnostic tool for COVID-. , 58(7) : 1095-1099.
Gao Y,Li T,Han M,Li X,Wu D,Xu Y,Zhu Y,Liu Y,Wang X,Wang L X,Med X .2020 .Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. , 92(7) : 791-796.
Gong J,Dong H,Xia SQ,Huang YZ,Wang D,Zhao Y,Liu WH,Tu SH,Zhang MM,Wang Q,Lu FE. .2020 .Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19 pneumonia. BMC Infect Dis, 20(1) : 963.
Guan WJ,Ni ZY,Hu Y,Liang WH,Ou CQ,He JX,Liu L,Shan H,Lei CL,Hui DSC,Du B,Li LJ,Zeng G,Yuen KY,Chen RC,Tang CL,Wang T,Chen PY,Xiang J,Li SY,Wang JL,Liang ZJ,Peng YX,Wei L,Liu Y,Hu YH,Peng P,Wang JM,Liu JY,Chen Z,Li G,Zheng ZJ,Qiu SQ,Luo J,Ye CJ,Zhu SY,Zhong NS .2020 .Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med, 382(18) : 1708-1720.
Han Y,Zhang H,Mu S,Wei W,Jin C,Tong C,Song Z,Zha Y,Xue Y,Gu G .2020 .Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: A retrospective and observational study. Aging, 12(12) : 11245-11258.
Huang C,Wang Y,Li X,Ren L,Zhao J,Hu Y,Zhang L,Fan G,Xu J,Gu X,Cheng Z,Yu T,Xia J,Wei Y,Wu W,Xie X,Yin W,Li H,Liu M,Xiao Y,Gao H,Guo L,Xie J,Wang G,Jiang R,Gao Z,Jin Q,Wang J,Cao B .2020 .Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. , 395(10223) : 497-506.
Huang Y,Tu M,Wang S,Wang S,Chen S,Zhou L,Wang M,Zhao Y,Zeng W,Huang Q,Xu H,Liu Z,Guo L. .2020 .Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis. Travel Med Infect Dis, 36 : 101606.
Japa ES .2020 .COVID-19 and iron dysregulation: Distant sequence similarity between hepcidin and the novel coronavirus spike glycoprotein: A potential hint at the possibility of local iron dysregulation in COVID19. , 15(1) : 19.
Ji D,Zhang D,Chen Z,Xu Z,Zhao P,Zhang M,Zhang L,Cheng G,Wang Y,Yang G,Liu H,Li B,Ji J,Lau G,Qin E .2020 .Clinical characteristics predicting progression of COVID-19. , : .
Koyama K,Katayama S,Tonai K,Shima J,Koinuma T,Nunomiya S T .2019 .Biomarker profiles of coagulopathy and alveolar epithelial injury in acute respiratory distress syndrome with idiopathic/immunerelated disease or common direct risk factors. Crit. Care, 23(1) : 283.
Liu Y,Yang Y,Zhang C,Huang F,Wang F,Yuan J,Wang Z,Li J,Feng C,Zhang Z,Wang L,Peng L,Chen L,Qin Y,Zhao D,Tan S,Yin L,Xu J,Zhou C,Jiang C,Liu L C .2020 .Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. , 63(3) : 364-374.
Matsumoto H,Kasai T,Sato A,Ishiwata S,Yatsu S,Shitara J .2019 .Association between C-reactive protein levels at hospital admission and longtermmortality in patients with acute decompensated heart failure. Heart Vessels, 34(12) : 1961-1968.
Mo P,Xing Y,Xiao Y,Deng L,Zhao Q,Wang H,Xiong Y,Gao Z,Liang S,Luo K,Chen M,Song T,Ma S,Chen Z,Zheng X,Cao R,Wang Q,F Q,Zhang Y Q .2020 .Clinical characteristics of refractory COVID19 pneumonia in Wuhan, China. Clin. Infect Dis, 73(11) : e4208-e4213.
Neves J,Haider T,Gassmann M,Muckenthaler MU M .2019 .Iron Homeostasis in the Lungs-A Balance between Health and Disease. Pharmaceuticals (Basel), 12(1) : 5.
Pan F,Ye T,Sun P,Gui S,Liang B,Li L,Zheng D,Wang J,Hesketh RL,Yang L,Zheng C .2020 .Time course of lungchanges on chest CT during recovery from 2019 novel corona-virus (COVID-19). , 295(3) : 715-721.
Qin C,Zhou L,Hu Z,Zhang S,Yang S,Tao Y,Xie C,Ma K,Shang K,Wang W,Tian DS .2020 .Dysregulation of immune response in patients with coronavirus 2019 (COVID-19. Clin. Infect. Dis., 71(15) : 762-768.
Rodriguez-Morales AJ,Cardona-Ospina JA,GutierrezOcampo E,Villamizar-Pena R,Holguin-Rivera Y,Escalera-Antezana JP,Alvarado-Arnez LE,BonillaAldana DK,Franco-Paredes C,Henao-Martinez AF,Paniz-Mondolfi A,Lagos-Grisales GJ,Ramirez-Vallejo E,Suárez JA,Zambrano LI,Villamil-Gomez WE,Balbin-Ramon GJ,Rabaan AA,Harapan H,Dhama K,Nishiura H,Kataoka H,Ahmad T,Sah R .2020 .Clinical, laboratory and imaging features of COVID19: A systematic review and meta-analysis. Travel Med, 34 : 101623.
Ruan Q,Yang K,Wang W,Jiang L,Song J .2020 .Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patientsfrom Wuhan. China. Intensive Care Med, 46(5) : 846-848.
Sadeghi-Haddad-Zavareh M,Bayani M,Shokri M,Ebrahimpour S,Babazadeh A,Mehraeen R,Moudi E,Rostami A,Barary M,Hosseini A,Bijani A,Javanian M .2021 .C-reactive protein as a prognostic indicator in COVID-19 patients. , : 5557582.
Sarzi-Puttini P,Giorgi V,Sirotti S,Marotto D,Ardizzone S,Rizzardini G,Antinori S,Galli M .2020 .COVID-19, cytokines and immunosuppression: What can we learn from severe acute respiratory syndrome? Clin. , 38(2) : 337-342.
Shah A,Frost JN,Aaron L,Donovan K,Drakesmith HJCC K .2020 .Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19. , 24(1) : 320.
Shoenfeld Y .2020 .Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning. Autoimmun Rev., 19(6) : 102538.
Sproston NR,Ashworth JJ .2018 .Role of C-reactive protein at sites of inflammation and infection. Front Immunol, 9 : 754.
Tan C,Huang Y,Shi F,Tan K,Ma Q,Chen Y,Jiang X,Li X .2020 .C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J. Med, 92(7) : 856-862.
Tang N,Li D,Wang X,Sun Z X .2020 .Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb Haemost, 18(4) : 844-847.
Varga Z,Flammer AJ,Steiger P,Haberecker M,Andermatt R,Zinkernagel AS,Mehra MR,Schuepbach RA,Ruschitzka F,Moch H F .2020 .Endothelial cell infection and endotheliitis in COVID-19. , 395(10234) : 1417-8.
Wang N,Luo C,Liu H,Yang X,Hu B,Zhang W,Li B,Zhu Y,Zhu G,Shen X,Peng C,Shi Z C .2019 .Characterization of a new member of alphacoronavirus with unique genomic features in rhinolophus bats. Viruses, 11(4) : 379.
Wang D,Hu B,Hu C,Zhu F,Liu X,Zhang J,Wang B,Xiang H,Cheng Z,Xiong Y,Zhao Y,Li Y,Wang X,Peng Z X .2020 .Clinical characteristics of 138 Hospitalized Patients With 2019 novel coronavirusinfected pneumonia in Wuhan, China. , 323(11) : 1061-9.
Warusevitane A,Karunatilake D,Sim J,Smith C,Roffe C C .2016 .Early diagnosis of pneumonia in severe stroke: clinical features and the diagnostic role of C-reactive protein. PLoS One, 11(3) : e0150269.
Wang L .2020 .C-reactive protein levels in the early stage of COVID-19. , 50(4) : 332-334.
Wang G,Wu C,Zhang Q,Wu F,Yu B,Lv J,Li Y,Li T,Zhang S,Wu C,Wu G,Zhong Y .2020 .Creactive protein level may predict the risk of COVID19 aggravation. Open Forum Infect. Dis., 7(5) : 153.
Wagner J,DuPont A,Larson S,Cash B,Farooq A .2020 .Absolute lymphocyte count is a prognostic marker in Covid-19: A retrospective cohort review. Int. J. Lab Hematol, 42(6) : 761-765.
Xie M and Chen Q ,MERS-CoV. Int .2020 .Insight into 2019 novel coronavirus An updated interim review and lessons from SARS-CoV and. J. Infect Dis, 94 : 119-24.
Xiong Y,Sun D,Liu Y,Fan Y,Zhao L,Li X,Zhu W .2020 .Clinical and high-resolution CT Features of the COVID-19 infection: Comparison of the Initial and Follow-up Changes. , 55(6) : 332-339.
Xu Z,Shi L,Wang Y,Zhang J,Huang L,Zhang C,Liu S,Zhao P,Liu H,Zhu L,Tai Y,Bai C,Gao T,Song J,Xia P,Dong J,Zhao J,Wang FS .2020 .Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 8(4) : 420-422.
Yan CH,Faraji F,Prajapati DP,Boone CE,DeConde AS CE .2020 .Association of chemosensory dysfunction and COVID-19 in patients presenting with influenzalike symptoms. Int. Forum Allergy Rhinol., 10(7) : 806-813.
Yang X,Yu Y,Xu J,Shu H,Xia J,Liu H,Wu Y,Zhang L,Yu Z,Fang M,Yu T,Wang Y,Pan S,Zou X,Yuan S,Shang Y .2020 .Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. Lancet Respir Med, 8(5) : 475-81.
Zhang L,Long Y,Xiao H,Yang J,Toulon P .2018 .Use of D-dimer in oral anticoagulation therapy. Int. J. Lab Hematol, 40(5) : 503-507.
Zhang L,Yan X,Fan Q,Liu H,Liu X,Liu Z,Thromb Z .2020 .D-dimer levels on admission to predict inhospital mortality in patients with Covid-19. , 18(6) : 1324-9.
Zhao Q,Meng M,Kumar R.,Wu Y,Huang J,Deng Y,Yang Z,L. Z .2020 .Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and metaanalysis. Int. J. Infect Dis, 96 : 131-5.
Zhou F,Yu T,Du R,Fan G,Liu Y,Liu Z,Xiang J,Wang Y,Song B,Gu X,Guan L,Wei Y,Li H,Wu X,Xu J,Tu S,Zhang Y,Chen H,Cao B H .2020 .Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet., 395(10229) : 1054-1062.
Zhu N,Zhang D,Wang W,Li X,Yang B,Song J,Zhao X,Huang B,Shi W,Lu R,Niu P,Zhan F,Ma X,Wang D,Xu W,Wu G,Gao GF,Tan W,Med N. Engl. J. .2020 .A Novel Coronavirus from Patients with Pneumonia in China, 2019. , 382(8) : 727-733.
0

Citations

0

Downloads

70

Views